Belite Bio BLTE
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 40th percentile, 5-year average -57.2x
Near the bottom of its 5-year range · 19th percentile, 5-year average 11.3x
#4861 of 5331 stocks by PB (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 8.66 | – | 11.31 | 19% (cheaper than usual) | #4861 of 5331 (1 = cheapest) |
| PE | -57.87 | -85.50 | -57.19 | 40% (cheaper than usual) | – |
| PS | – | 38.46 | 0.00 | – | – |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BLTE.
Sign in to join the discussion.